On 2025-05-08, INmune Bio, Inc. (INMB) announced earnings per share of $-0.43 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.43.
The next expected annoucement date for quarterly earnings is 2025-08-07, with an average estimated earnings per share of $-0.37 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.43 | $-0.43 |
| 2025-03-27 | 2024-12-31 | $-0.53 | $-0.40 |
| 2024-10-31 | 2024-09-30 | $-0.49 | $-0.60 |
| 2024-08-01 | 2024-06-30 | -- | $-0.50 |
| 2024-05-09 | 2024-03-31 | -- | $-0.61 |
| 2024-03-28 | 2023-12-31 | -- | $-0.47 |
| 2023-11-01 | 2023-09-30 | -- | $-0.48 |
| 2023-08-07 | 2023-06-30 | -- | $-0.36 |
| 2023-05-03 | 2023-03-31 | -- | $-0.36 |
| 2023-03-02 | 2022-12-31 | -- | $-0.32 |
| 2022-11-02 | 2022-09-30 | $-0.59 | $-0.43 |
| 2022-08-03 | 2022-06-30 | $-0.50 | $-0.38 |
| 2022-05-05 | 2022-03-31 | $-0.60 | $-0.39 |
| 2022-03-03 | 2021-12-31 | $-0.56 | $-0.55 |
| 2021-11-03 | 2021-09-30 | $-0.43 | $-0.55 |
| 2021-08-04 | 2021-06-30 | $-0.33 | $-0.44 |
| 2021-05-05 | 2021-03-31 | $-0.28 | $-0.32 |
| 2021-03-04 | 2020-12-31 | $-0.33 | $-0.24 |
| 2020-11-05 | 2020-09-30 | $-0.17 | $-0.36 |
| 2020-08-05 | 2020-06-30 | $-0.20 | $-0.20 |
| 2020-05-14 | 2020-03-31 | $-0.21 | $-0.19 |
| 2020-03-11 | 2019-12-31 | $-0.25 | $-0.22 |
| 2019-11-08 | 2019-09-30 | $-0.20 | $-0.28 |
| 2019-08-12 | 2019-06-30 | $-0.18 | $-0.04 |